HSAC Responds to Proposal for Reorganizing the NIH
Vol. 8 - November 2024
Healthspan Action Recent News
Ex-GSK CEO takes up board post at aging and obesity biotech BioAge
By Nick Paul Taylor - Fierce Biotech - BioAge Labs has appointed former GSK CEO Jean-Pierre Garnier as chair of its board of directors, bringing the pharma veteran back into the...
Cardiovascular health: Powering longevity through heart-healthy living
By National Heart, Lung, and Blood Institute - Supporting cardiovascular health is important at every age, and early influences can improve health outcomes years later As the...
Diabetes took over her life, until a stem cell therapy freed her
By Carolyn Y. Johnson - The Washington Post - For years, Amanda Smith and her husband were jolted awake at night by a buzz-buzz-beep — an alarm warning that her blood sugar was...
Welcome to the Healthspan Action Coalition (HSAC)
We are a worldwide, cross-sector societal movement helping to establish a new paradigm in medicine
Healthspan Action Coalition (HSAC) supports new medical strategies that intervene in the aging process and offer much better treatment of age-related diseases (dementia, heart disease, cancer, frailty, and many more).
Advancing the Cause of Improving Healthspan
Bringing together science, industry, regulatory bodies and patient advocacy groups with a common goal of relieving human suffering.
Promoting Public Policy for More Longevity research
Supporting legislative action that seeks to address the aging process and its role in virtually all noncommunicable diseases.
Delivering an Increased Healthspan to All Populations
Fighting to remove barriers to healthcare and address the drivers of health inequality for our entire population, both young and old.
The Coalition’s priorities include:
- Increasing government funding for meritorious healthspan research, funding and filling clinical trials.
- Prioritizing an accelerated regulatory process for healthspan treatments and cures, enacting evidence-based regulations that keep pace with innovation.
- Advancing public and private sector payment policies supporting patient access to regenerative medicine and other advanced therapies aimed at extending the healthspan.
- Lessening preclinical animal testing and substituting, where feasible, support for and deployment of advanced technologies, including precision medicine, organ-on-a-chip, AI, organoids and tissue-engineering.
- Addressing the progress, implications and global adoption of the World Health Organization ICD-11 codes declaring aging is a disease-related condition.
- Driving workforce development initiatives, including within technical schools and community colleges, to build capacity and develop a skilled workforce for this highly technical field.
- Delivering an increased healthspan to all populations and communities by creating cross-sector collaborations and tools aimed at addressing disparities in the drivers of health, racism and bias, and structural flaws in the health system. All people should have the fair and just opportunity to achieve their full potential in every aspect of their health, longevity and well-being.
SUPPORTING HEALTHSPAN INITIATIVES WORLDWIDE
Promoting favorable policy and funding for scientific research, innovations and patient engagement
The coalition unites all stakeholders who have an interest in lessening the burden of diseases and conditions that affect not only the aged, but all patients worldwide who experience an enormous range of health conditions, all of which impact the healthspan.
Countries Represented
Combined Leadership Experience
“This new initiative fills a glaring unmet need. We’ve come to believe that the field of biological aging is the new frontier, and patients are the key driving force to advancing an extension of the healthspan, the number of years we can live free of disease and disability.”
Bernard Siegel
Executive Director and Founding Board Member